Diabetes Mellitus, Insulin-Dependent
Item
subjects with type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetes disease length
Item
duration of diabetes for at least 12 months
boolean
C0011847 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Insulin Aspart
Item
treatment with insulin aspart for at least 3 months before trial start
boolean
C1708521 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi) below 35.0 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c below 12.0%
boolean
C0019018 (UMLS CUI [1])
Insulin Dosage Total U/kg/day
Item
total insulin dosage more than 1.4 iu/kg/day
boolean
C0021641 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0439810 (UMLS CUI [1,3])
C1532634 (UMLS CUI [1,4])
Recurrent severe hypoglycemia Interferes with Study Subject Participation Status
Item
recurrent major hypoglycaemia that may interfere with trial participation (as judged by the investigator)
boolean
C0342316 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
Loss of hypoglycemic warning
Item
known hypoglycaemia unawareness as judged by the investigator
boolean
C0342317 (UMLS CUI [1])
Hypersensitivity
Item
known hypersensitivity or allergy
boolean
C0020517 (UMLS CUI [1])